New, more sensitive, and precise testing reveals a troubling finding in the treatment of Lyme disease. As this study reveals, many doctors may often be prescribing the incorrect antibiotics, due to the narrow focus on B. burgdorferi. In twenty-seven people from sixteen states, 96% were found to have other Borrelia strains than B. burgdorferi, many of which cannot be treated with the same antibiotics.
Limitations of Conventional Lyme Testing
Treatment-resistant, chronic and apparent relapsing Lyme disease (borreliosis), with its oft associated co-infections which worsen the illness, though once debated, is now well-documented in the scientific literature. Chronic Lyme disease has reached the true status of a global pandemic, though largely unappreciated by the media and mainstream medicine.
Conventional diagnostic lab testing, such as Western Blot, ELISA, and Conventional Bacteria PCR testing for the dectectin of Borrelia spirochete of Lyme disease has had limited success. Most types of conventional tests having high false-negative results, with as little as 30% sensitivity, meaning as much as 70% of people tested, actually have the infection, but never get treatment due to their lab test coming back negative. These people fall between the cracks of medicine as their body and lives fall apart as doctors do not know what is wrong with them, assuming the tests were correct. (See Fig. 1)
The painful reality is that conventional labs which are not focused solely on testing for Lyme disease, often are not as diligent in their testing, not getting paid more to find the bacteria or not, and seeming to forget that there is a real and desperate person at the other end of the blood test. Unfortunately beyond this, the medico-political environment regarding the existence of chronic Lyme disease also gets in the way of getting many, if not most conventional physicians to order the test, even at the pleading of their patients.
New Testing Pinpoints Acute and Chronic Infections
In 2019 a new, highly sensitive test (See Fig. 1 Phage Test) was developed by the University of Leicester, in England, and performed by the R.E.D Laboratory, for the diagnosis of Borrelia infections. This test is so sensitive and the testing process so rigorous, that the test is nearing 100% accurate, at >80% sensitivity to detecting not just the presence of Borrelia burgdorferi, but all of the 20 types of Borrelia that can cause tick-borne and vector-borne illness. This test is call the Phelix Borrelia-Phage Test, and is such a breath of fresh air in that the test results come back not with encrypted, hard to determine bands, as in Lyme Western Blot tests, but instead clearly state, Positive or Negative and the exact type of Borrelia infection or multiple types of Borrelia strains that you have, without needing your doctor to interpret the results.
Doctors in the United States or any other country can order this test.
- Only ONE person out of 27 from 16 states in the study had B. burgdorferi.
- Please note most had B. Miyamotoi followed by strains that cause relapsing fever, and most had more than one strain of Borrelia.
- The study shows that Bb is likely not the real culprit behind many cases of chronic Lyme – which in turn means many are not getting the proper treatment.
- The paradigm of “classic” Lyme based upon the Bb model needs to be expanded to include symptoms unique to the other strains as well as the various coinfections often present.
- Dr. Jernigan offers a new Borrelia-phage-based targeted treatment that has been developed and documented by repeated Phelix Borrelia-Phage testing to rapidly eliminate only the types of Borrelia a person has been found positive, with no harm to the body, with minimal Herx reactions, and no harm to good bacteria.
- To learn more about Bacteriophages and INPT treatment please click on the hyperlink.
- If you would like to participate in their one to two week INPT programs please contact them at www.biologixcenter.com/get-treatment/. Financial assistance is available for those with chronic illness of any type, who desire treatment at Biologix Center and are struggling financially.